These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38561118)

  • 1. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
    Cao J; Zhu C; Cao Z; Ke X
    Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
    Du M; Gu J; Liu C; Liu N; Yu Z; Zhou C; Heng W; Cao Z; Wei F; Zhu K; Wang Y; Zhang W; Xue X; Zhang Y; Qian J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):154. PubMed ID: 35459258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
    Yang Z; Liu J; Lu Y
    Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody.
    Wu H; Wei G; Luo L; Li L; Gao Y; Tan X; Wang S; Chang H; Liu Y; Wei Y; Song J; Zhang Z; Huo J
    Biomater Res; 2022 Dec; 26(1):77. PubMed ID: 36494759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
    Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
    Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma.
    Wang H; Chen Y; Wei R; Zhang J; Zhu J; Wang W; Wang Z; Wupur Z; Li Y; Meng H
    Adv Mater; 2024 Apr; 36(15):e2309591. PubMed ID: 38113900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
    Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma.
    Xu Y; Du L; Han B; Wang Y; Fei J; Xia K; Zhai Y; Yu Z
    J Nanobiotechnology; 2023 Jul; 21(1):243. PubMed ID: 37507707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
    Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
    Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional bone cement for synergistic magnetic hyperthermia ablation and chemotherapy of osteosarcoma.
    Liang B; Zuo D; Yu K; Cai X; Qiao B; Deng R; Yang J; Chu L; Deng Z; Zheng Y; Zuo G
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110460. PubMed ID: 31923975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment.
    Chu X; Mi B; Xiong Y; Wang R; Liu T; Hu L; Yan C; Zeng R; Lin J; Fu H; Liu G; Zhang K; Bian L
    Biomaterials; 2025 Jan; 312():122714. PubMed ID: 39079462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.